Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Gastrointestinal Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02810418
What this trial is testing

Mesothelin-Targeted Immunotoxin LMB-100 Alone or in Combination With Nab-Paclitaxel in People With Previously Treated Metastatic and/or Locally Advanced Pancreatic Ductal Adenocarcinoma and Mesothelin Expressing Solid Tumors

Who this might be right for
NeoplasmsPancreatic Neoplasms
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)WithdrawnNCT06090318
What this trial is testing

Milademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A Loss

Who this might be right for
Advanced Solid TumorCDKN2ANSCLC+7 more
Rain Oncology Inc
Testing effectiveness (Phase 2)Study completedNCT01505413
What this trial is testing

Phase 2 Study of Erlotinib, Gemcitabine and Oxaliplatin Combination Chemotherapy to Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Soonchunhyang University Hospital 33
Large-scale testing (Phase 3)Study completedNCT00427713
What this trial is testing

Capecitabine and Oxaliplatin or Standard Follow-Up Care in Treating Patients Who Have Undergone Surgery for Locally Advanced Rectal Cancer

Who this might be right for
Colorectal Cancer
Cancer Research UK 800
Testing effectiveness (Phase 2)UnknownNCT01197118
What this trial is testing

Postoperative Sequence Chemoradiotherapy Compared With Chemotherapy Alone for Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Huazhong University of Science and Technology 40
Testing effectiveness (Phase 2)Study completedNCT02335918
What this trial is testing

A Dose Escalation and Cohort Expansion Study of Anti-CD27 (Varlilumab) and Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumors

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck (SCCHN)Ovarian Carcinoma-Enrollment CompletedColorectal Cancer (CRC)-Enrollment Completed+2 more
Celldex Therapeutics 175
Not applicableStudy completedNCT00007618
What this trial is testing

The Identification of Prognostic Factors of Late Stage Disease, Particularly Those That Are Modifiable, That Might Explain the Worsened Prognosis With Colorectal Cancer Among Veterans.

Who this might be right for
Colorectal Cancer
US Department of Veterans Affairs
Testing effectiveness (Phase 2)Study completedNCT03878472
What this trial is testing

Neoadjuvant Immunotherapy for Resectable Gastric Cancer

Who this might be right for
Gastric Cancer
Qilu Hospital of Shandong University 25
Early research (Phase 1)Ended earlyNCT05061537
What this trial is testing

Study of PF-07263689 in Participants With Selected Advanced Solid Tumors

Who this might be right for
Renal Cell CancerMelanomaNon-Small-Cell Lung Cancer+7 more
Pfizer 13
Testing effectiveness (Phase 2)UnknownNCT05739045
What this trial is testing

Nivolumab Combined With SOX Used in the Perioperative Treatment

Who this might be right for
Immune SuppressionGastric Cancer
Xiangdong Cheng 46
Testing effectiveness (Phase 2)UnknownNCT01308645
What this trial is testing

Evaluating the Safety and Efficacy of SB Injection in Patients With Advanced or Primary Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
SBPharmaceutical IND, Co., LTD 30
Early research (Phase 1)Study completedNCT01975831
What this trial is testing

Evaluate MEDI4736 in Combination With Tremelimumab

Who this might be right for
Breast CancerOvarian CancerColorectal Cancer+2 more
Ludwig Institute for Cancer Research 104
Early research (Phase 1)Study completedNCT04106856
What this trial is testing

Losartan and Hypofractionated Rx After Chemo for Tx of Borderline Resectable or Locally Advanced Pancreatic Cancer

Who this might be right for
Borderline Resectable Pancreatic AdenocarcinomaLocally Advanced Pancreatic Ductal AdenocarcinomaLocally Advanced Unresectable Pancreatic Adenocarcinoma+4 more
University of Utah 22
Large-scale testing (Phase 3)Not Yet RecruitingNCT07653451
What this trial is testing

Precision Medicine for Immunotherapy-Resistant Advanced Esophageal Cancer

Who this might be right for
Esophageal Squamous Cell Carcinoma
Peking University Cancer Hospital & Institute 90
Testing effectiveness (Phase 2)Ended earlyNCT05169437
What this trial is testing

Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors

Who this might be right for
Solid TumorBreast TumorColon Tumor, Malignant+9 more
Tempus AI 22
Testing effectiveness (Phase 2)UnknownNCT03951337
What this trial is testing

64Cu-ATSM PET/CT in Rectum Cancer (TEP 64Cu-ATSM-Rectum)

Who this might be right for
Rectal Cancer
Institut Cancerologie de l'Ouest 70
Early research (Phase 1)Ended earlyNCT06466187
What this trial is testing

SGN-MesoC2 in Advanced Solid Tumors

Who this might be right for
Carcinoma, Non-Small-Cell LungOvarian NeoplasmsPancreatic Adenocarcinoma+4 more
Seagen, a wholly owned subsidiary of Pfizer 19
Large-scale testing (Phase 3)Study completedNCT03984214
What this trial is testing

Efficacy and Safety of Dronabinol in the Improvement of Chemotherapy-induced and Tumor-related Symptoms in Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Non-resectableChemotherapy-induced Nausea and VomitingPancreatic Cancer Metastatic
Arbeitsgemeinschaft medikamentoese Tumortherapie 109
Early research (Phase 1)WithdrawnNCT05043987
What this trial is testing

Dose Escalation and Expansion Study of CPO102, an Anti-claudin 18.2 ADC in Patients With Advanced Cancers

Who this might be right for
Pancreatic CancerGastric Cancer
Conjupro Biotherapeutics, Inc.
Testing effectiveness (Phase 2)Ended earlyNCT05188209
What this trial is testing

Evaluate the Efficacy and Safety of MRG003 in Patients With Advanced Gastric Cancer.

Who this might be right for
Advanced or Metastatic Gastric CancerAdvanced or Metastatic Gastroesophageal Junction Carcinoma
Lepu Biopharma Co., Ltd. 6
Next Page